Comparison of mouse strains for susceptibility to styrene-induced hepatotoxicity and pneumotoxicity

被引:35
作者
Carlson, GP
机构
[1] School of Health Sciences, Purdue University, West Lafayette, IN
来源
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH | 1997年 / 51卷 / 02期
关键词
D O I
10.1080/00984109708984020
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Styrene is known to cause both hepatotoxicity and pneumotoxicity in mice. Strain differences have been reported by other investigators suggesting that Swiss mice are less susceptible than non-Swiss mice to styrene-induced liver damage. in this study, A/J and C57BL/6 mice were found to be similar to non-Swiss albino (NSA) mice in susceptibility whereas CD-1 (Swiss) mice were more resistant to hepatotoxicity as assessed by serum sorbitol dehydrogenase levels and pneumotoxicity as determined by gamma-glutamyltranspeptidase and lactate dehydrogenase measurements in bronchoalveolar lavage fluid. Styrene was hepatotoxic in CD-1 mice treated with pyridine to induce CYP2E1. CYP2E1 apoprotein levels and p-nitrophenol hydroxylase activities in control and pyridine-induced mice were similar in the two strains. Hepatic and pulmonary microsomal preparations from both strains metabolized styrene to styrene oxide at similar rates. CD-1 mice were as susceptible as the NSA mice to the effects of styrene oxide. The data suggest that there are no differences in the bioactivation of styrene to styrene oxide or innate susceptibility to the active metabolite that would account for the differences between the CD-1 and NSA mice.
引用
收藏
页码:177 / 187
页数:11
相关论文
共 26 条
  • [1] REVIEW OF THE TOXICOLOGY OF STYRENE
    BOND, JA
    [J]. CRC CRITICAL REVIEWS IN TOXICOLOGY, 1989, 19 (03): : 227 - 249
  • [2] MEASUREMENT OF THE HEMOGLOBIN N-(2-OXOETHYL)VALINE ADDUCT IN ETHYL CARBAMATE-TREATED MICE
    CAI, J
    MYERS, SR
    HURST, HE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 131 (01) : 73 - 79
  • [3] INDUCTION BY PYRIDINE OF CYTOCHROME-P450IIE1 AND XENOBIOTIC METABOLISM IN RAT LUNG AND LIVER
    CARLSON, GP
    DAY, BJ
    [J]. PHARMACOLOGY, 1992, 44 (03) : 117 - 123
  • [4] FOUREMAN GL, 1989, J PHARMACOL EXP THER, V248, P492
  • [5] Pneumotoxicity and hepatotoxicity of styrene and styrene oxide
    Gadberry, MG
    DeNicola, DB
    Carlson, GP
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1996, 48 (03): : 273 - 294
  • [6] GERLACH U, 1983, METHOD ENZYMAT AN, V3, P112
  • [7] HARRIS C, 1986, J PHARMACOL EXP THER, V236, P144
  • [8] IBA MM, 1993, TOXICOLOGIST, V13, P345
  • [9] KAUL KL, 1987, J PHARMACOL EXP THER, V243, P384
  • [10] KIM HS, 1993, J PHARMACOL EXP THER, V267, P927